Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis
NCT02908581 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2017-07-13
Summary
This study will be conducted to observe any change in fungal pattern on skin of arsenicosis patients before and after administration of iron (150 mg) and folic acid (0.5 mg) tablets.
Conditions
- Chronic Arsenic Poisoning
Interventions
- DRUG
-
Administered orally once daily
- DRUG
-
Iron 150 mg and Folic acid 0.5 mg
Iron will be administered with folic acid orally
Sponsors & Collaborators
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
lead OTHER
Principal Investigators
-
Mir Misbahuddin, PhD · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
-
Priyanka Moitra, MBBS · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2017-04-30
- Completion
- 2017-07-31
Countries
- Bangladesh
Study Locations
More Related Trials
-
Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome
NCT02262312 ·Status: COMPLETED
-
Pilot Study of Metformin for Patients With Fanconi Anemia
NCT03398824 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Iron Deficiency Anemia With Pregnancy
NCT02005588 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
NCT00981045 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
NCT01922479 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
NCT01039636 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
NCT01160198 ·Status: COMPLETED ·Phase: PHASE3
-
Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia
NCT06631612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients
NCT02198508 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
NCT02905539 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
NCT00704028 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
NCT01546415 ·Status: COMPLETED ·Phase: PHASE4
-
Ferric Carboxymaltose Methemoglobinemia Study
NCT06958822 ·Status: COMPLETED
-
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00110266 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
NCT00004412 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
NCT00386126 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Early Antenatal Support for Iron Deficiency Anemia
NCT04278651 ·Status: RECRUITING ·Phase: PHASE4
-
Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
NCT01725789 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
NCT00703937 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
NCT00061763 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3
-
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
NCT01250951 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
NCT02826681 ·Status: TERMINATED ·Phase: PHASE2
-
IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 ·Status: UNKNOWN ·Phase: PHASE3
-
Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103 ·Status: COMPLETED ·Phase: PHASE4